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1 Introduction 
1.1 Sudden unexpected deaths in infancy 
1.1.1 HISTORICAL ASPECTS 
Early reference 
The oldest mention of a sudden unexpected infant death dates back to about 500 B.C. and 
the story of King Solomons famous decision told in the First Book of Kings in the Old 
Testament: “This woman’s child died in the night: because she overlaid it”1. Throughout 
the Middle Ages and well into the Reformation, overlaying was the accepted explanation of 
sudden infant deaths2. Regulated by King Christian V’s Norwegian Law of 1687, the 
authorities were to solve whether or not the death was due to an accident or intentional 
infanticide2. If the overlaying was thought to be an accident, the punishment was pillory at 
the entrance of church followed by public confession. If considered manslaughter, the 
punishment was sentence by the secular court.  
 19th century: Status thymo-lymphaticus 
In the late 1800s and early 1900s, sudden infant deaths were attributed to so-called “internal 
suffocation” induced by an abnormally large thymus. Designated “Status thymo-
lymphaticus”, the theoretical concept was that the enlarged thymus could compress the 
trachea and thus hinder the respiration3. The hypothesis was not rejected until the 1940s as 
it eventually became apparent that large thymuses indeed represented a normal 
developmental stage for infants at this age4. The misunderstanding clearly emphasizes the 
importance of appropriate controls in research on this subject. 
1950s - Hypogammaglobulinemia 
During the 1950s and 1960s, sudden unexplained deaths in infancy, mentioned as crib 
deaths or cot deaths attracted growing interest from pathologists and physicians. To spare 
parents the ordeal of an inquest which would necessarily follow an unnatural death, discrete 
morphological findings observed at autopsy were sometimes attributed to the cause of 
death5.  Minimal inflammation of the lining of the larynx were observed in several cases 
and promoted the hypothesis that viral infections could be a causative factor4. However, 
attempts to demonstrate evidence of viremia in victims of crib death failed. 
 
In 1954, it was purported that crib deaths could be due to hypogammaglobulinemia, as low 
levels of serum gammaglobulin were found in victims of crib death compared to standards 
available at that time, which were normal adult values6. Valdes-Dapena demonstrated a few 
years later that the serum levels in victims of crib death did not differ from live infants at 
the same age7. Other theories of causative factors to crib death evolving in this period were: 
Hypersensitivity to cow’s milk, hypoparathyroidsim, and “reshaping” of myocardial 
conduction system within the first month of life4. All these theories were rejected by 
subsequent research. 
 
Defining SIDS 
Lack of uniform clinical terminology created difficulties for cilinicians and researchers as 
well as parents of deceased infants. Parents were desperate for a definition that could dispel 
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unwarranted suspicion of child abuse and provide the medical basis for appropriate 
counseling8. In 1963 and 1969 the National Institute of Child Health and Human 
Development (NICHD) arranged international conferences on the causes of sudden death in 
infants. A consensus was made in defining the phenomenon of unexplained infant deaths by 
the term Sudden Infant Death Syndrome (SIDS)9. Formulated by Beckwith, SIDS was 
defined as: 
 
  “The sudden death of any infant or young child, which is unexpected by history, and 
in which a thorough post mortem examination fails to demonstrate an adequate cause of 
death”.  
 
The definition emphasized the necessity of an autopsy to classify sudden infant deaths. A 
degree of diagnostic stability and focused research was achieved with this definition, as 
well as improved ability to compare statistics from different regions and countries.  
 
The present (San Diego) definition10, approved at the SIDS International Conference in 
Edmonton, Canada in 2004, was based on a proposal by Beckwith for a new SIDS 
definition which he presented in Sidney 199211. According to this definition, SIDS is: 
 
“The sudden unexpected death of an infant <1 year of age, with onset of the fatal 
episode apparently occurring during sleep, that remains unexplained after a thorough 
investigation, including performance of a complete autopsy and review of the 
circumstances of death and the clinical history.”  
 
The San Diego definition provides a number of specifications for the diagnosis (i.e. age 
criteria, type of investigations, interpretation of findings) used for subclassification into 
category I (“pure”) SIDS or category II SIDS. Criteria for category I SIDS include: age 
between the third week and ninth month, a normal clinical history including a full term 
pregnancy and no evidence of accidental death in the sleeping environment (i.e. bed-
sharing or prone sleeping on soft surface). Fully investigated, yet totally unexplained infant 
deaths that do not meet the strict requirements are placed in a category II SIDS, to some 
extent corresponding to the borderline term in the Nordic protocol12. The San Diego 
definition also introduces the term “Unclassified” sudden infant death, referring to cases 
incompletely investigated or that do not meet the criteria for category I or II SIDS, but for 
which alternative diagnoses of natural and unnatural conditions are equivocal.  
1970s: SIDS mortality rates increasing 
During the 70s and 80s the SIDS rates in several western countries were rising, instigating 
increased awareness from researchers13. Several experimental studies were initiated in order 
to try to explain the enigma. Different theories of explanations were put forward, some 
were disputed and others seemed hopeful, yet at the time unable to fully explain the 
concept. Proposed theories included that SIDS was due to neurological malformations, 
heart arrhythmias, circadian autonomic disturbances, infection, immunological 
disturbances, endocrine or metabolic disorders as well as extrinsic causes: overlaying, 
suffocation, poisoning. A selection of these theories is presented below:  
 
Steinschneider brought forward the apnea hypothesis14 based on the documentation that 
episodes of apnea preceded several cases of SIDS. The hypothesis led to the development 
of apnea monitors for the use of parents in order to be alarmed if theirs babies stopped 
breathing. The use of monitors and the apnea theory were brought into miscredit as it later 
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appeared that two of the infants described by Steinscheider as dying suddenly and 
unexpectedly in fact were homicides.  
 
The heart arrhythmia theory was fronted by Schwartz15. He argued that ECG screening had 
the potential to save infants from dying of SIDS15. His group later performed ECG of 
33000 newborn infants, 24 of which ended up dying of SIDS16. Long QT interval was 
detected in 12 of these 24 ECG diagrams. (The heart arrhythmia hypothesis has recently 
been “confirmed” by studies performed in collaboration with our research group in Oslo, 
documenting mutations or polymorphisms in the Long QT genes in 9.5% of SIDS victims 
and none of the controls17).  
 
Kahn proposed that autonomic dysfunction or impairment could be the cause of SIDS18. 
Infants who had been studied and subsequently died from SIDS, compared with surviving 
infants, had higher baseline heart rates, lower heart rate variability, and imbalance in 
parasympathetic/sympathetic tone16;19-21. 
 
In 1976, Naeye presented findings of brain stem astrogliosis and six other tissue markers 
for chronic or repeated hypoxia in sudden infant death22. The brain stem findings were 
reproduced by several other investigators23-26. However, astrogliosis takes several days 
(weeks) to develop and probably represents status subsequent to hypoxic episodes prior to 
death, i.e. in fetal life.  The hypoxia theory gained support when Rognum and Saugstad in 
1988 presented their studies on hypoxanthine, the breakdown product of purine 
metabolism27. They found elevated hypoxanthine levels in vitreous humor in SIDS 
compared to violent deaths, which indicated that a proportion of the SIDS victims probably 
had sustained episodes of hypoxia in close proximity to the time of death. 
Break-through – the hazard of prone sleeping  
In the early 70s, Dr Shirley Tonkin in New Zealand, Dr Susan Beal in Australia and  
Dr DeJonge in the Netherlands visited each family that had lost an infant and learnt that the 
main common feature was that the babies had slept prone28-30. The observations triggered 
large case control studies which confirmed the relationship between prone sleeping position 
and SIDS31;32 The back-to-sleep campaigns of the late 80s and early 90s led to a dramatic 
drop in infant mortality rates around the world33-35. The change of infants’ sleeping position 
from prone to back represents the success story of SIDS research. Norway was one of the 
first countries to implement the back-to-sleep campaign, induced by the effort of Dr. 
Markestad in Bergen in late 1989. The incidence in Norway dropped from 142 cases of 
SIDS (2.4 ‰ of all live births) in 1989 to 34 cases three years later (0.6 ‰), and has 
continued to decline to around 20 cases per year after the millennium (0.3-0.4 ‰, Figure 1) 
(www.ssb.no).  
 
SIDS research in the 80s and 90s was dominated by epidemiological studies. Demographic 
and individual risk factors for SIDS were detected and reproduced in different populations 
in large multi-center studies. The most important risk factors are presented in section 1.1.3 
below.
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The Fatal triangle hypothesis 
In 1992-93 three analogous theories for the explanation of SIDS was presented by different 
research milieus, although mentioned by Wedgewood already in 197211;36. These theories 
imply that for an infant to die of SIDS, three conditions must be fulfilled:  
 
1. A predisposition (i.e. inborn genetic error or intrauterine exposure to nicotine) 
2. A vulnerable developmental stage (i.e. the first months of life) and  
3. An exogenous trigger event (prone sleeping, infection, overheating). 
 
The three-hit models proved helpful in order to relate epidemiological and biochemical 
research. Experimental studies as well as studies of the mucosal immune system in SIDS 
victims and controls during the last 20 years have generated knowledge and theories of 
possible predisposition and features of the vulnerable stage in infancy important for the 
understanding of SIDS13;37. The Fatal triangle hypothesis (Figure 2) will be further 
addressed in the general discussion 5.1 below.  
 
 
Figure 2. The Fatal triangle model explaining SIDS. From Rognum and Saugstad38. 
 
 
1.1.2 Diagnostic challenges – what is unexplained and what is 
explained 
As part of the NORD SIDS study in the early 90s, forensic pathologists from the Nordic 
countries worked together to establish a protocol for the investigation of sudden infant 
death39;40. The Nordic protocol divided sudden unexpected infant deaths into three 
categories: pure SIDS, borderline SIDS and non-SIDS. The pure SIDS cases were totally 
unexplainable and the non-SIDS cases explained deaths. In between the fully explained and 
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totally unexplained deaths, the borderline SIDS diagnosis referred to cases of sudden infant 
death in which pre-existing congenital disorders or clinical symptoms, and/or post-mortem 
findings were present, but not considered severe enough to explain the cause of death. 
Definite pathologic criteria for diagnostic classification were agreed upon, and 
upplemented in all the Nordic countries.  
 after the post-mortem 
vestigation categorized as SIDS or Borderline SIDS (Figure 3).  
ions 
nd a standardized approach to the autopsy and death scene investigation is necessary.  
 
europathological examination, histology of all organs and targeted genetic screening45;46.  
 in the research period, the death scene investigations 
were of value for the diagnosis48. 
s
 
Several conditions involving all organ systems may be responsible for sudden death in 
infancy41. If an adequate post mortem examination is not performed, including a forensic 
autopsy, death scene investigation and review of the history, the possibility of determining 
the cause of death may be lost11. Evidence of neglect, abuse and homicide can be subtle, 
and inflicted asphyxia may be indistinguishable from SIDS42. Before 1989, approximately 
80% of all sudden deaths in infancy remained unexplained,
in
 
After the decline in SIDS rate, the relative percentage of explained deaths has increased, in 
particular deaths due to diseases and accidents. Moreover, in later years several cases of 
infant deaths due to neglect and child abuse have also been disclosed (Figure 3). These 
changes are not likely to be due to a shift in diagnostic evaluation, as shown by a 
reevaluation of the cases examined prior to 1989, classifying the cases according to the 
Nordic criteria of 199243. The “new” manifestation of sudden infant death, represent a 
tremendous challenge for the medical experts and police involved in such investigat
a
 
Ruling out inflicted deaths may have serious medicolegal implications. Efforts have been 
made to reach agreement on standardized international protocols explaining the baseline 
investigations that need to be performed41;44. The baseline forensic autopsy of sudden 
deaths in infancy includes radiological, microbiological and toxicological investigations,
n
 
International agreement has been reached as to when specific pathological changes may 
constitute the cause of death41;45. How to interpret information obtained from clinical 
history and from death scene investigation is under current discussion12;47. The SIDS 
definition emphasizes the necessity of death scene investigations to exclude other causes of 
death10. In my opinion, a prerequisite for classification of sudden infant deaths are multi-
disciplinary case conferences where circumstantial, clinical and pathological findings are 
being evaluated47;48. In Norway, death scene investigations are not mandatory, and in 
general not performed, unless the autopsy reveals suspicion of a possibly inflicted death. 
During a research project in South east Norway between 2001 and 2004 however, we were 
able to carry out such surveys48. The importance of examining the death scene was shown 
by the fact that in 31% of the cases
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Figure 3. Relative percentage of unexplained and explained sudden infant deaths in Southeast Norway 
in three time periods, 1984-89 (before the back-to-sleep campaign), 1990-2000 and 2001-05. 
1990-2000
n=312
  
1.1.3 SIDS EPIDEMIOLOGY 
Demographic factors 
Boys are more likely to die from SIDS than girls at a ratio of 3:249;50. SIDS is also 
associated with prematurity and low birthweight as well as low maternal age50;51. Before the 
drop in SIDS rate, most of the victims were aged between 2 and 4 months52. The back-to-
sleep campaign decreased and broadened this classical age peak. Approximately 60-65% of 
the sudden infant deaths (SIDS and explained deaths) occur during the winter months from 
October to March, but the seasonal variation has become less apparent after the drop in 
SIDS rate51. With the decreasing rate, socio-economic factors have become more obviously 
associated with SIDS. Blair et al found that prior to 1991, 28% of the SIDS parents were 
unemployed, compared to 48% after that year49. On the other hand, the proportion of 
males/females has remained consistent49;51.  
 
It has been argued that breastfeeding has a protective effect, but no significant effect of 
breast- /bottle feeding has been shown in epidemiological studies 50;51;53. Siblings of SIDS 
victims are at increased risk for SIDS50, which may be attributed to unrecognized genetic 
predisposition and/or to common environmental factors, however, homicide must in such 
cases also be ruled out.   
Prone sleeping position 
The rate of placing infants prone for sleep has decreased substantially after the successful 
campaigns. However, more than 50% of infants older than 2 months of age are still found 
dead in the prone position54. The dangers of prone sleeping position have been attributed to 
the possibility of rebreathing of expired air, which contains high levels of carbon dioxide55. 
Some infants with blunted arousal systems may fail to turn their head or lift their face56. 
Prone sleeping infants with fever are particularly at risk57. The prone position raises the 
upper airway surface temperature and an increased risk for bacterial toxin production has 
been hypothesized58. Prone sleeping has also been shown to increase the total amount of 
time infants spend asleep and, in particular, the time spent in quiet sleep, a state of reduced 
arousability 21;59. 
Smoking 
The most important environmental risk factor after prone sleeping is smoking during 
pregnancy60. Prenatal exposure to tobacco smoke affects fetal growth and is associated with 
increased risk for prematurity and low birth weight61 and delayed lung growth62. Functional 
impairment of the respiratory response to hypoxia has also been shown in infants exposed 
to tobacco smoke in utero63. Post-natal exposure to tobacco smoke also seems to be a 
separate risk factor for SIDS60. High levels of the nicotine breakdown-product cotinine has 
been detected in SIDS victims64, suggesting that exposure to nicotine has occurred within 
the last hours prior to death. Nicotine has a direct inhibitory effect on neurologic 
development and is associated with decreased arousal to hypoxia65 and alterations in the 
autonomic control66. 
Bed-sharing 
In the aftermaths of the back-to-sleep campaign several studies have shown an increased 
risk for sudden infant death associated with adult-infant bed sharing. In 2005 we presented 
data demonstrating that the SIDS rate in infants below two months of age has not been 
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altered by the back-to-sleep campaign, and that 73% of SIDS victims in this age group were 
found dead in a bed-sharing situation54. Bed-sharing may be hazardous when the infant is 
younger than 4 months of age and the bed-sharing parent is a smoker or is influenced by 
drugs or alcohol50;54;67. On the other hand, safe bed-sharing is likely to facilitate 
breastfeeding and enhance parent-infant interactions68;69, and our study disclosed that bed-
sharing tended to be more common in controls than in SIDS victims for infants older than 4 
months of age.   
Soft bedding and overheating 
Soft bedding and soft surfaces, including pillows, sheepskins and porous mattresses have 
been associated with higher risk for SIDS56;57. In particular, a strong interaction has been 
found between prone sleep position and soft bedding surface57. During infancy the 
metabolic activity increases substantially and the ratio of body surface to mass decreases. 
Infants show a very wide range of metabolic activity and heat production during sleep70;71. 
The main factor likely to compromise thermoregulation, with increased risk of SIDS, is 
head covering72. It has been argued that the risk of overheating could possibly be reduced 
by the use of an infant sleeping bag72.Some of the “classical” risk factors are not merely 
restricted to cases of SIDS, but are also associated with deaths due to infectious disease49 
(Table 1). 
 
 
 
Table 1. Comparison of epidemiological variables in SIDS, Borderline SIDS, deaths due to 
infections and accidental/inflicted deaths below 1 year of age investigated at the Institute of forensic 
medicine in Oslo between 1984 and 2005. 
 
 
  
SIDS Borderline 
SIDS 
Deaths due 
to infections 
Accidental/ inflicted 
deaths 
  n=208 n=64 n=42 n=21 
     
Median age in days (IQR) 103 (84) 89 (98) 88 (131) 176 (219) 
Winter occurence 61 % 56 % 55 % 52 % 
Male predominance 56 % 61 % 69 % 48 % 
Prone sleeping* 72 % 57 % 62 %  
Bed-sharing infants < 2 mo of age# 57 % 52 % 57 %  
          
*Data regarding sleeping position was present in 180/208 SIDS, 52/64 Borderline SIDS and 34/42 deaths due 
to infections. 
#Data regarding occurrence of bed-sharing or not was present in 42/43 SIDS, 23/25 Borderline SIDS and 
14/15 deaths due to infections below 2 months of age. 
 
 
 - 14 - 
1.1.4 SIDS AND INFECTION 
More than 60 years ago, Werne hypothesized that an ordinary seasonal respiratory infection 
may cause the death of an otherwise healthy infant73. Prior to the back-to-sleep campaign 
more than half of SIDS victims reportedly had a mild infection during the week preceding 
death52. In fact, for the “classical” SIDS victims between 2 and 4 months of age, 
approximately 2/3 had recently underwent a slight infection and interestingly, this  
population subgroup was most affected by the back-to-sleep campaign 52.  The typical 
winter peak in SIDS rate corresponds with endemics of respiratory infections. Lindgren et 
al demonstrated a significant correlation between outbreaks of whooping cough due to B. 
Pertussis infections and SIDS mortality rate74. It has also been postulated that the SIDS rate 
is related to outbreaks of respiratory virus epidemics 75-77(Figure 6 in section 5.1.3 below).  
 
The hazards of sleeping prone have also been attributed to increased risk for infections. The 
prone position raises the upper airway surface temperature, which enhances the growth 
conditions for pathogenic bacteria such as Staphylococci and Neisseriae58. Staphylococci 
toxins and endotoxins from enteric bacteria such as Clostridium and E. Coli have been 
suggested as contributory factors to SIDS, inducing shocklike reactions and fever78. 
Endotoxins have been detected in individual SIDS cases, but have not been investigated in 
large case-control studies79.   
 
1.1.5 SIDS AND THE IMMUNE SYSTEM 
Mild inflammatory changes in the wall of the bronchioli in SIDS victims was demonstrated 
by Paltauf in the late 1800s3. During the last 20 years, extensive immunohistochemical 
examination of the mucosal immune system in SIDS has been performed on tissue samples 
form the SIDS Biobank of the Institute of Forensic Medicine at the University of Oslo. 
Salivary glands, tonsils, tracheal walls, and intestinal mucosa have all shown immune 
stimulation in SIDS, though to a somewhat lesser degree than in victims of infectious 
deaths80-83. The findings are summarized in figure 4.  
 
The newborn infant is immunologically naive, as the acquired immune system is dependent 
upon interaction with microbial antigens. Studies have demonstrated that the acquired 
mucosal immune system undergoes a rapid development in the first week and months after 
birth84-86. In contrast, the amount of secreted anti-microbial enzymes such as amylase, 
lysozyme and lactoferrin decreases shortly after delivery84. Furthermore, in the first weeks 
and months after birth, the amount of circulating maternal immunoglobulins from fetal life 
drops. This obvious imbalance in mucosal immunity probably reflects a vulnerable period 
of life. It has been postulated that components of the innate immunity in this age period 
play an important role in the protection against infections87;88.  
 
A large proportion of SIDS is probably preceded by repeated hypoxia, gasping and 
bradycardia shortly prior to death13. The downregulation of respiration is most likely due to 
events in the central nervous system. In 1989 Guntherroth proposed that cytokines might 
constitute a link between activation in mucosal (peripheral) immunity and the central 
nervous system89. In 1995 Vege et al demonstrated that half of the SIDS victims had 
interleukin 6 (IL-6) levels in cerebrospinal fluid in the same range as infants who died from 
infections such as meningitis and septicemia90. IL-6 is a pro-inflammatory cytokine 
mediating fever and an acute phase response. In a later study, it was demonstrated that 
SIDS victims with high IL-6 levels in the cerebrospinal fluid also had slight signs of 
infection before death, and showed increased number of either IgA cells or HLA DR 
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expression in the laryngeal epithelium82. An Australian study on IL-6 gene polymorphisms 
revealed that a genotype associated with high IL-6 responses was more frequent in SIDS 
victims compared to controls91. However, no such association was found in the Norwegian 
population92. Interleukin 10 (IL-10), an anti-inflammatory cytokine, has also been 
implicated in SIDS: IL-10 gene polymorphisms were found to be associated with sudden 
deaths due to infections93. SIDS took an intermediate position between deaths due to 
infections and controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Summary of the immunological and biochemical findings in material from the Institute of 
Forensic Medicine, University of Oslo. 
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1.2 Helicobacter pylori 
In 1983 Warren and Marshall described the growth of a spiral shaped bacilli in biopsy 
specimen from the gastric mucosa94. Soon after the bacterium was linked with chronic 
antral gastritis and peptic ulceration94. Initially, the bacterium was classified as 
Campylobacter pylori but in 1989 was included in a new genus, Helicobacter, and renamed 
Helicobacter pylori95. H. pylori is a S-shaped or curved gram-negative rod. The principal 
reservoir for H. pylori infection appears to be the human stomach, especially the antrum.  
1.2.1 Prevalence of H. pylori infection 
H. pylori is a common bacterium and approximately 50% of the world's population has 
been estimated to be infected96. In most western countries the prevalence in the adult 
population is between 20-40% compared to 70-85% in developing countries. The increased 
prevalence with age is largely due to an age-cohort effect rather than new infections. 
Colonization typically takes place in early childhood and it has long been assumed that the 
encounter with bacteria results in a lifelong infection. In the Nordic countries the 
prevalence in children is presumably low, between 2-5% in pre-school children97;98. 
1.2.2 Transmission and colonization 
When H. pylori is introduced in the human stomach, it may pass through to the intestine or 
it may colonize the gastric mucosa99. After colonizing the stomach, H. pylori either causes 
an acute infection or is spontaneously eliminated. In children such a spontaneous 
eradication can occur several times before colonization takes place100. Whether this 
depends on the infectious dose of a given H. pylori strain or results from exposure to 
several H. pylori strains with different characteristics is unknown. 
 
The route of transmission is not totally clarified, however is most likely fecal-oral or oral-
oral101. Person-to-person transmission within the family appears to be the predominant 
mode of transmission, particularly from mothers to children and among siblings, indicating 
that intimate contact is important102. There is now emerging evidence that acquisition of 
Helicobacter pylori infection in childhood does not necessarily result in persistent 
infection103;104.  
 
The ability of H. pylori to colonize and establish infection in the gastric mucosa is 
dependent upon some basic characteristics: urease, flagellae, a particular shape, and 
adhesins105. The bacteria produces urease which converts urea to ammonia ions that 
neutralize the acidic gastric juice, enabling H. pylori to survive and multiply in the stomach. 
Colonizing the mucin layer that covers the epithelial cells, the flagellae give  
H. pylori the mobility to withstand rhythmic gastric contractions and penetrate the gastric 
mucosa. The curved s-shape and flagellae both enables the bacteria to bore through the 
mucin layer, and due to production of specific adhesion molecules the bacteria is able to 
adhere to gastric epithelial cells.  
 
Recently, it has been recognized that H. pylori has the ability to convert into a coccoid form 
when exposed to detrimental environmental circumstances 106. Clustered coccoid bacteria 
were visualized in biopsies from the gastric mucosa of dyspeptic patients by electron 
microscopy. The biopsies were PCR-positive, yet culture-negative, and seemingly void of a 
host immune response 107. 
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1.2.3 The immunological response 
H. pylori releases large amounts of small water soluble antigens eliciting the host epithelial 
cell production of chemokines and pro-inflammatory cytokines such as IL-8 and IL-6105. 
Recent studies have shown that innate components with the ability to recognize pathogen-
associated molecular patterns i.e. Toll Like Receptors and Surfactant protein D are 
powerful modulators of the chemotaxis and primary immune response in H. pylori 
infection108-110. The infiltration of polymorphonuclear cells establishes the primary 
infection associated with acute gastritis111. As H. pylori antigens are presented to cells in 
the lymphatic organs, the humoral and cell-mediated immune responses are activated. 
Approximately 4 weeks after the initial infection, antibodies against H. pylori appear in the 
blood. The infiltration of mononuclear lymphocytes changes the inflammation from an 
acute inflammation to chronic superficial gastritis111.  
1.2.4 Clinical importance 
Acute infection may be associated with a transient mild illness characterized by 
epigastric pain and nausea, but may also pass unnoticed. Most symptoms usually resolve 
within 2 weeks. Clinical data on acute infection is based mainly on a number of cases 
where investigators and volunteers have been infected112. Probably in the majority of 
patients, H. pylori does not cause symptoms, and the infection persists without any 
clinically evident disease112.  
 
In adulthood, H. pylori infection is involved in the pathogenesis of gastritis and peptic 
ulcers and is associated with gastric adenocarcinoma and MALT lymphoma111. H. pyloris 
role in gastrointestinal disease in childhood is yet incompletely understood. H. pylori is 
considered to be the major cause of the duodenal ulcer which is very uncommon in 
pediatrics, whereas the association between H. pylori and more common illnesses like non-
ulcer dyspepsia, recurrent abdominal pain and gastric outlet obstruction remains 
controversial101;113. In recent years, a variety of extradigestive disorders, including 
migraine, cardiovascular diseases, autoimmune disorders, and liver diseases have also been 
related to H. pylori infection114. Marshall, the discoverer of the Helicobacter bacilli, 
postulated in 1997 a link with SIDS115. The hypothesis initiated a few case-control studies 
which did not produce consistent findings116;117, and Marshall later rejected the 
hypothesis118. 
 
1.3 Surfactant and the collectins 
1.3.1 Physiological properties of surfactant 
Pulmonary surfactant is a complex of lipids and proteins that lines the interior of the lung. 
Presence of surfactant has been detected in the lungs of all major vertebrates and it has been 
argued that the evolution of the surfactant system must have been a prerequisite for the 
evolution of airbreathing119. Surfactant prevents alveolar collapse by reducing the surface 
tension across the air/liquid interface of the alveoli120. Lack of surfactant causes a 
disturbance of alveolar gas exchange. This can be seen in premature infants suffering from 
respiratory distress syndrome (RDS), a major cause of neonatal death. Introduction of 
surfactant replacement therapy has significantly reduced the morbidity and mortality of 
preterm infants. Surfactant is also involved in several defense mechanisms in the lung. It 
prevents the increase in airway resistance in allergen-challenged animals121 and enhances 
mucociliary clearance of harmful contaminants122.  
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The surfactant complex consists of approximately 90% lipid and 10% protein. 
Phosphatidylcholine is the dominant lipid and is present in disaturated form 
(dipalmitoylated phospatidylcholine DPPC) that enables surfactant to withstand very high 
surface pressure, thus preventing alveolar collapse. Other phospholipids and cholesterol 
constitute the major remaining lipids. Partial atelectasis of the lungs is a common feature at 
autopsy of SIDS victims, but is also found in other causes of infant deaths. Talbert and 
Southall proposed that a defect in surfactant composition or synthesis may trigger the death 
mechanism in SIDS123. They hypothesized that defective surfactant at a critical period in 
lung development may cause large areas of the lungs to collapse suddenly, greatly reducing 
the oxygen stores. However, the significance of the hypothesis remains unclear and 
surfactant has not received much attention from SIDS researchers in later years. 
1.3.2 Surfactant proteins 
Four surfactant proteins have been identified, SP-A, SP-B, SP-C and SP-D. These are 
produced and secreted into the conductive airways and alveolar space within the surfactant 
lipid-protein complex mainly by non-ciliated bronchial cells and pulmonary type II 
pneumocytes. 
 
Much of the current knowledge of the surfactant proteins have evolved from studies on 
transgenic animals. SP-B and SP-C are small hydrophobic molecules integrated in the 
phospholipid layer and are involved in reducing the surface tension. Lack of SP-B causes a 
fatal respiratory failure in infancy, characterized by dysmorphic type II alveolar cells with 
small lamellar bodies, and alveolar collapse124. Lack of SP-C results in severe lung disease 
resembling interstitial pneumonitis and severe emphysema124. In humans, mutations in the 
SP-B gene inherited as an autosomal recessive genetic disorder have been identified, 
resulting in death in the neonatal period125. Distinct mutations in the SP-C gene have also 
been identified in humans and are associated with increased risk for respiratory distress, 
interstitial pneumonitis and the development of chronic lung disease125.  
 
SP-A and SP-D are large hydrophilic glycoproteins. Their main function is related to host 
defense and regulation of inflammation. SP-A is the most abundant surfactant protein and is 
believed to play a role in organizing the structure and affecting the function of surfactant 
lipids126;127.  
1.3.3 The collectins 
The collectins consist of SP-A, SP-D and the serum protein mannose-binding lectin (MBL). 
They are powerful constituents of the innate immune defense, involved in opsonization, 
chemotaxis and clearance of pathogens88. They are characterized by a collagen-like triple 
helical region linked to a carbohydrate recognition domain (CRD) at the carboxy terminal 
end (Figure 5). SP-A is mainly produced in respiratory epithelium128;129, whereas SP-D has 
been located in epithelial cells on all mucosal surfaces, and has been called the innate 
counterpart of IgA in the adaptive immune system130. MBL is an acute phase protein 
produced by hepatocytes. The collectins are large macromolecules that are joined in the N-
terminal region and present in oligomeric forms. The tertiary structure of SP-D resembles a 
cart-wheel with a diameter of more than 100 nm and with the CRDs radiating out to the 
perimeter131 (Figure 5).  The CRDs of the collectins are able to bind calcium-dependently to 
lipid and carbohydrate-derived microbial substances. Bacterial cell wall components like 
lipoteichoic acid of Gram-positive bacteria and lipopolysaccharides (LPS) of Gram-
negative bacteria are ligands for the collectins. Most of these components occur as 
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repeating units that enhance the interaction between collectins and microbes. Normal 
mammalian cells do not present such pathogen-associated molecular patterns characteristic 
of microorganisms.  
 
 
 
 
Figure 5. Schmatic drawing and electron microscopic photographs of collectins.  
From Holmskov et al. 200388. 
 
 
MBL has the ability to activate complement through an independent pathway. Clinical 
studies have disclosed that MBL insufficiency increases morbidity of respiratory tract 
infections in early childhood87 and is critical in avoiding sepsis and septic shock in 
critically ill patients132. The binding of SP-A and SP-D to microbial surfaces leads to 
inhibition of bacterial and fungal growth133;134, opsonization for phagocytosis by 
macrophages135 as well as aggregation and neutralization136. SP-D has been shown to play a 
role in the host response to H. pylori infection, being able to agglutinate and greatly reduce 
the motility of H. pylori bacteria108. SP-A and SP-D transgenic mice subjected to bacterial 
infection present compensatory cytokine expression, increased inflammation and oxidant 
production137.  
 
2 Objectives of the study 
 
1. To investigate the prevalence of Helicobacter pylori infection in Norwegian 
newborn infants and small children. Furthermore to detect possible epidemiological 
associations of H. pylori infection with factors such as mode of delivery, nutrition, 
household members and parents’ country of origin. Previous studies from western 
countries have detected low prevalence of H. pylori infection in small children, but 
few have investigated very young infants and neonates. Developmental studies are 
required in SIDS-research for comparative investigation. (Paper I) 
 
2. To study the role of Helicobacter pylori infection in SIDS and other sudden 
unexpected deaths in infancy. A link between H. pylori and SIDS was proposed in 
1997. Small, qualitative studies have thus far failed to provide evidence of a 
significant association, but large sample investigations have not been performed.  
 
3. To investigate the developmental features of the innate component Surfactant 
protein A (SP-A) by evaluating the immunohistochemical expression in human lung 
tissue. The aim was to develop a method for evaluation of SP-A immune staining in 
order to investigate a possible role for SP-A in SIDS.  
 
4. Some genetic variants of mannose-binding lectin, MBL, are associated with low 
plasma levels and a clinical state of minor immune deficiency. The first goal of this 
study was to investigate whether the two other collectins: surfactant protein A (SP-
A) and surfactant protein D (SP-D) also may be genetically determined. The 
association between genetic variants and the immunohistochemical expression of 
SP-A and SP-D has not been studied previously. The second goal of this study was 
to investigate possible associations between SP-A, SP-D and MBL genotypes and 
SIDS.  
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3 Material and Methods 
3.1 Subjects and tissue samples 
The patients were cases of sudden unexpected deaths in infancy investigated at the Institute 
of forensic medicine, University of Oslo in the period between 1989 and 2004. Included in 
paper III are a few cases of intrauterine fetal deaths as well as cases of sudden unexpected 
deaths in childhood and in adulthood. The median time-interval from death to autopsy was 
19 hours (range 5-77) and all autopsies were performed by the same forensic pathologists 
(TOR, ÅV, MAR, ASP), according to the Nordic diagnostic criteria for SIDS39. 
Clinicopathological information about the patients is given in the respective papers (II, III, 
IV). In papers II and IV only infants of ethnic Norwegian citizen were included in the 
studies, to avoid selection bias due to the high prevalence of H. pylori among immigrants102 
and to take advantage of the genetic homogeneity of the Norwegian population. Body fluids 
and tissue samples were obtained during autopsy. 
 
The Nordic SIDS criteria39;41 implies that no cause of death has been revealed after a 
thorough evaluation of the circumstances of death, review of the medical history and a full 
post-mortem investigation including total body skeletal X-ray, toxicological and 
microbiological investigation. Examination of the death scene was performed by forensic 
experts between 2001 and 2004. In the cases from 1989-2000, medical doctors/health 
personnel and/or the local police had been called to the scene according to Norwegian 
regulations.  
 
Included in papers I and II were also live infant controls, who were recruited in either the 
maternity ward at Rikshospitalet in Oslo or in outpatient mother-and-child clinics in the 
cities of Drammen and Droebak (Marienlyst and Frogn helsestasjon). From the newborn 
infants, the fecal (meconium) specimens were taken right after their first defecation at day 1 
or 2 after birth. In the outpatient clinics, infants and children who presented with a fresh 
sample of stool in their diapers were included. A few parents also brought to the outpatient 
clinic a fresh sample of the child’s stool collected at home.  
 
3.2 HpSA ELISA 
Stool specimens were stored in an ultrafreezer at -800C. The Premier Platinum Helicobacter 
pylori Stool Antigen (HpSA) test (Meridian Bioscience Inc., Ohio, USA) was performed 
according to the instructions of the manufacturer. Approximately 200 mg of feces was 
diluted and incubated in microwells coated with polyclonal rabbit antibodies recognizing H. 
pylori antigens and then with rabbit anti-H. pylori antibody conjugate in the presence of 
color developing solution. The OD values were determined at 450 nm wave length. 
According to the manufacturer, tests were to be regarded positive when OD  0.160, 
equivocal when 0.140  OD   0.160, and negative when OD   0.140. All samples were 
tested twice using dissimilar test tubes and reagents, and performed blind without 
knowledge of the other test results. Both tests had to yield an OD  0.160 for a positive 
result.  
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3.3 DNA extraction and PCR 
3.3.1 H. pylori  
To extract bacterial DNA from feces, the QIAamp Stool Mini Kit (Qiagen GmbH, Hilden 
Germany), was used. The method is supposed to allow removal of DNA-damaging 
substances and PCR inhibitors present in the stool. The DNA extraction was performed 
according to the manufacturer's instructions with minor modifications suggested by 
Sicinschi et al138. A H. pylori strain from the local collection at the Institute of 
Microbiology, Rikshospitalet, was used as positive control for the PCR assay. DNA from 
H. pylori was isolated using Prepman Ultra (Applied Biosystems, California, USA). 
 
PCR amplification with Helicobacter specific primers was performed in 25-μl reaction 
volumes containing Tris buffer. The primers consisted of two specific 16S rDNA 
oligonucleotides, which generated a 138-bp DNA product139. Fifty thermocycles were 
performed at 60oC and the DNA lysates were analyzed by electrophoresis on an agarose 
gel, each trial included a positive and a negative control. 
 
PCR products and primers were sent via http://www.medprobe.com to Lark Technologies 
(Essex, UK) who performed sequencing. Obtained sequences were analyzed with the 
Sequence Scanner 1.0 program (freeware) and subjected to homology search analysis using 
the NCBI databases and BLAST algorithm http://www.ncbi.nlm.nih.gov/BLAST/. 
 
3.3.2 Collectins 
DNA was extracted from blood/spleen using standard extraction methods. In patients in 
whom specimens of blood or spleen were not available, DNA was extracted from alcohol-
fixed paraffin-embedded tissue by removal of paraffin and digesting with proteinase (paper 
IV). 
 
A sequence specific primer-PCR method as described by Pantelidis et al140 was applied for 
genotyping of the single nucleotide polymorphisms (SNPs) in SP-A1 at aa19, aa50, aa62, 
aa133, and aa219, in SP-A2 at aa9, aa91, aa140 and aa223, and in SP-D at aa11 and aa160. 
To achieve reproducible results for the SNP at aa140 within SP-A2, the control primers 
were changed from the recommended 63/64 yielding a 784 bp control product to the one 
used for several of the other PCR reactions, 210/211, yielding a 249 bp product. Minor 
modifications in the amount of primers in the PCR reactions were also performed. The two 
SP-A genes have been shown to be in marked linkage disequilibrium. The SP-A1 and SP-
A2 alleles cosegregate as one unit (haplotype) denoted 6An /1An141. The haplotype 
frequencies were determined on the basis of homozygous genotypes, and haplotyping from 
the heterozygous genotypes was based on the highest likelihood as described by Rämet et 
al142. 
 
The MBL genotyping was performed by the use of PCR and restriction fragment analysis. 
The primers, reaction conditions and restriction enzymes are given in paper IV. The 
different fragments were visualised under ultraviolet light by gel electrophoresis on agarose 
gels. 
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3.4 Immunohistochemistry 
3.4.1 Material 
Tissue samples of central and peripheral part of the lung, palatine tonsils, submandibular 
gland and the wall of the stomach and the duodenum were obtained at autopsy performed 
within 71 hrs of death (median 23 hrs). The sections were cut at 4 m and fixed in 96% 
cold ethanol or 4% formaldehyde. Tissue samples showing signs of extensive autolysis 
were excluded from the study. A small selection of lung samples was fixed in 4% 
formaldehyde and processed for double immunohistochemical staining. 
 
3.4.2 Staining procedures 
The antibodies used in the immune staining studies with peroxidase (enzyme) technique 
were monoclonal mouse anti-human SP-A IgG1(Hyb 238-4), mouse anti-human SP-D IgG1 
(Hyb245-1), mouse anti-human CD 68 IgG3 (Clone PG-M1, DAKO, Glostrup, Denmark), 
and mouse anti- H. pylori IgG (B-0471, DAKO) (Table 2). Immune staining was performed 
manually (SP-A, SP-D) or automated (H. pylori) with the ChemMate EnVision Detection 
Kit Peroxidase/DAB+ (K5007; DAKO), which includes (I) applying a peroxidase blocking 
solution to avoid unspecific staining, (II) incubating sections with the target antibodies, (III) 
incubating with polymer which adheres to the target antibodies and (IV) applying substrate 
to yield specific DAB+ (horseradish brown) staining of targets. Counterstaining was finally 
briefly performed with hematoxylin (purple blue).  
 
Double staining was performed in a small selection of lung tissue specimens with the 
ChemMate EnVision G/2 Doublestain System (K5361; DAKO), targeting SP-A and 
additionally CD 68 for identification of phagocytes. Following incubation with primary 
antibody SP-A, peroxidase polymer and DAB+ (horseradish) substrate, the slides were 
washed and specimens covered with Doublestain Blocking solution, and subsequently 
incubated with CD 68 antibody, alkaline phospatase polymer and Permanent Red substrate. 
 
 
Table 2.  Specifics of the antibodies used in immunohistochemical staining 
 
Specificity Product Ab-type 
Working 
dilution 
Stock 
concentration 
Peroxidase 
substrate 
Fluorescence 
conjugate 
SP-D Mouse anti-human IgG1 1:1200 1 mg/ml DAB  
SP-A Mouse anti-human IgG1 1:5500 1 mg/ml DAB  
CD 68 Mouse anti-human IgG3 1:200 1 mg/ml Permanent red  
H. pylori Rabbit anti-human IgG 1:40 0.32 mg/ml DAB  
IgA Goat anti-human IgG 1:40 1 mg/ml  FITC 
IgM Goat anti-human IgG 1:20 1 mg/ml  TXRD 
IgG Goat anti-human IgG 1:20 1 mg/ml  TXRD 
 
 
The expression of IgA, IgG and IgM immunocytes in the gastric and duodenal mucosa was 
evaluated by paired immune fluorescence technique as described in previous studies80;82. 
Briefly, alcohol-fixed 4 m thick sections were incubated with fluorochrome-conjugated 
goat anti-human antisera to the immunoglobuline isotypes IgA, IgM and IgG (Southern 
Biotechnology Associates, Birmingham, Alabama, USA). Antibody reagents were applied 
in pairs of contrasting colors (FITC – fluorescein isothiocyanate (green) or TXRD – texas 
red). 
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3.4.3 Microscope and photography 
Observations were performed using low (40x - 400x) power light microscope. For 
examination of H. pylori presence in gastric tissue, high power (630x) light microcopy was 
performed. A Leitz Aristoplan fluorescence microscope equipped with a Ploem-type 
epiilumminator for narrow band excitation and selective filtration of green and red emission 
colors was used for evaluation of immune fluorescence staining. 
Digital photographs were captured using a Leitz digital camera and the softwares 
Leica/Adobe photoshop 2.0.  
 
3.4.4 Evaluation of immune staining 
Based on the observed staining pattern, a semi-quantitative scoring system was developed 
for evaluation of the intensity and distribution of SP-A and SP-D immune staining in lung 
tissue. A scale from 0 to 3 was applied: With regard to intensity, a score of 0 represents no 
evident staining, 1 represents weak staining, 2 – moderately strong staining and  
3 - strong staining. With regard to distribution, a score of 0 means virtually no staining of 
cells, 1 represents less than 25% cells stained, 2 – between 25-50% of  cells stained (25-
75% for SP-A) and 3 –  staining of  more than 50% of the cells (75% for SP-A). A total 
score for SP-A and SP-D expression in the lungs as well as for SP-D expression in 
submandibular gland was calculated by multiplying the distribution and intensity scores. 
The detailed characteristics of the scoring systems are given in paper III and IV.  
 
With regard to the density of immunoglobuline producing cells, counting of immunocytes 
in the gastric/duodenal mucosa was performed by an ocular grid with grid area 0.01 mm2. 
Presence of IgA, IgM and IgG plasma cells (immunocytes) in the lamina propria and 
submucosa were counted, as reported by Stoltenberg et al80. The density of immunocytes in 
each sample was based on counting 20-25 grid fields which has been shown to be necessary 
to obtain a stable mean80;82. Only areas with preserved histologic structures were examined. 
These results are shown in figure 7 in the discussion below, but are not presented in any of 
the papers. 
 
The H. pylori immune staining in gastric tissue was evaluated blindly by a specialist in 
microbiology and pathology (ÅV) who had no information about case history or stool test 
findings. 
 
3.4.5 Reproducibility 
Blind evaluation of SP-A staining pattern and staining intensity by two different observers 
(ASP and TOR) showed a high degree of agreement (SP-A: Kappa=0.80). A blinded trial 
performed by the same observer on two different occasions showed a high degree of 
scoring reproducibility (SP-A: Kappa=0.90). 
Also for counting of immunocytes inter- and intraobserver reproducibility was satisfactory 
(Kappa=0.74 and 0.60 respectively). The H. pylori immune stains were reevaluated blindly 
by ÅV and the reproducibility was good having the same result in 24 out of 26 reexamined 
cases. 
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3.5 Interleukin-6 measurement 
Interleukin-6 (IL-6) concentrations in CSF were measured by an ELISA kit (R & D 
Systems Inc., Minneapolis, USA), utilizing 100 l CSF and determining Optical Density at 
450 nm as previously described90.  
 
3.6 Statistical analysis 
The two-tailed Mann-Whitney U test was used for comparison of non-parametric variables 
between two groups. The frequencies of categorical variables such as individual alleles and 
haplotypes between the SIDS and control groups (paper IV) were compared using 2 x 2 
tables and the use of the 2 test. When the expected cell values were <5, the Fisher’s exact 
test was applied. Bivariate logistic regression was used to model the associations between 
H. pylori status and clinical variables (paper I), and to compare high/low SP-A expression 
scores and clinical variables (paper III). For testing variation in total SP-A scores with age, 
the Kruskal–Wallis one-way analysis was performed (paper III). For testing of inter- and 
intra-observer reproducibility, the Kappa test was applied (paper III and IV).  The level of 
significance was set to 0.05. Analyses were implemented by the use of SPSS version 14.02 
(SPSS, Chicago IL, USA).  
 
3.7 Registry and approval 
All studies were approved by the Committee for Medical Research Ethics in Southern 
Norway (REK sør, ref. nr. S-02272). The Helicobacter studies (paper I and II) were 
presented and approved by the Norwegian Social Science Data Services Detection (NSD, 
ref.nr 11414). The usage of autopsy material from a registered Biobank obtained during 
forensic investigations of infants for research purposes, has been approved by the 
Norwegian Dept of Health. The fecal specimens collected from live healthy infants also 
constitute a registered Biobank. 
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4 Summary of the results 
In this chapter the results from each paper are summarized. 
 
4.1 Publication I  
Stray-Pedersen A, Gaustad P, Stray-Pedersen B and Rognum TO. Helicobacter pylori stool 
antigen detection rate in newborn infants and small children. J Perinat Med. 
2007;35(2):155-8. 
 
Gastrointestinal colonization with Helicobacter pylori is generally believed to occur in 
infancy and result in a chronic lifelong infection.  The aim of this study was to investigate 
the prevalence of H. pylori infection in normal healthy neonates, infants and small children 
in Norway.  
 
Fecal samples from 249 Norwegian children aged 0 days -3 years were collected and tested 
for the presence of H. pylori antigen using the Premier Platinum HpSA immunoassay. For 
verification purposes, 52 samples (26 HpSA positive and 26 negative) were were analyzed 
with PCR targeting the 16 S rDNA Helicobacter gene and the PCR products were sequenced. 
 
Results: H. pylori antigen was detected in the feces from 52% (36/69) of the newborn 
infants, 15% (7/46) of infants aged between 7 days and 1 month, and 5% (7/134) of 
children aged between 1 month and 3 years. The H. pylori antigen detection rate in 
newborn infants was significantly associated with birth manner; 59% (30/51) of infants 
with normal vaginal births tested positive compared to only 10% (1/10) of infants delivered 
by cesarean section (p=0.02). Positive PCR results were found in 35% (9/26) of HpSA 
positive and 12% (3/26) of HpSA negative samples. Sequencing of PCR products revealed 
97-100% homology with gene sequences from both H. pylori and other Helicobacter 
species.  
 
Conclusions: The low H. pylori antigen detection rate in small children older than one 
month of age is in accordance with previous studies from western countries. The striking 
finding of a high H. pylori antigen detection rate in newborn infants, suggests that transient 
H. pylori colonization may occur in the neonatal period and that transmission of H. pylori 
may be related to birth and mode of delivery.  
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4.2 Publication II 
Stray-Pedersen A, Vege Å, Musse M, Rognum TO. Helicobacter pylori antigen in stool is 
associated with SIDS and sudden infant deaths due to infectious disease. Pediatr Res. 
2008 Jun 4. [Epub ahead of print] 
 
A possible link between Helicobacter pylori infection and SIDS was hypothesized in 1997, 
but has gained limited support by later studies. To test the hypothesis, stool specimens from 
a retrospective cohort of 160 sudden unexpected deaths in infancy and 156 live controls 
were investigated.   
 
The patients included in the study were 122 SIDS victims, 17 deaths due to infection, 10 
due to non-infectious disease and 11 accidental/violent deaths. The stool specimens were 
obtained at autopsy and stored at -80oC. Stool from live control infants were obtained from 
their diapers. Presence of H. pylori antigen was detected using the HpSA immunoassay. IL-
6 concentrations in CSF were measured in 147/160 cases. Gastric tissue specimens were 
evaluated by Giemsa and immunoperoxidase staining in 12 HpSA positive and 14 negative 
SIDS cases.  
 
Results: H. pylori antigen was detected in 8% (12/156) of the live controls compared to 
25% (30/122) of SIDS cases (p<0.001), 53% (9/17) of deaths due to infection (p<0.001), 
20% (2/10) of deaths due to non-infectious disease (p=0.20), and 9% (1/11) of 
accidental/violent deaths (p=0.60). In the classic age peak for SIDS, 1-5 months, 31% 
(21/67) of SIDS cases were HpSA positive compared to 1.5% (1/68) of live controls 
(p<0.001). Rod-like immunoperoxidase positive H. pylori organisms were identified in 
7/12 HpSA positive gastric antrum sections compared to 2/14 HpSA negative (p=0.038). 
Significantly elevated IL-6 levels in CSF were demonstrated in HpSA positive SIDS 
victims compared to HpSA negative victims (p=0.045).  
 
Conclusion: Detection of H. pylori antigen in stool is associated with SIDS and deaths due 
to infections. We hypothesize that H. pylori infection in infancy may be involved as the 
triggering pathogen for sudden death during the first five months after birth. 
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4.3 Publication III  
Stray-Pedersen A, Vege A, Stray-Pedersen A, Holmskov U, Rognum TO. Post-neonatal 
drop in alveolar SP-A expression – biological significance for increased vulnerability 
to SIDS? Pediatr Pulmonol. 2008 Feb;43(2):160-8. 
 
Surfactant protein A (SP-A) is a water-soluble large glycoprotein secreted into the lung 
alveoli by bronchiolar epithelial cells and type II pneumocytes. SP-A has a structural role 
within the surfactant system to prevent alveolar collapse, and being a part of the of the 
innate immune system, SP-A is a powerful modulator of inflammatory processes. The aim 
of this study was to evaluate the expression of SP-A in human lung tissue at various ages 
from fetal life to adulthood, with special regard to possible implications for sudden infant 
death syndrome (SIDS). Lung tissue specimens from 13 intrauterine-, 6 neonatal-, 108 
infant-, 19 childhood- and 14 adult deaths were obtained at autopsy.  Fifty-nine of the infant 
deaths studied were classified as SIDS, 29 had succumbed due to a disease and 20 were 
accidental/violent deaths. Immunohistochemical detection of SP-A using monoclonal 
antibodies was performed by microscopy of lung tissue specimens collected at autopsy. A 
scoring system was developed enabling semi-quantitative estimation of staining intensity 
and distribution.  
 
Results: SP-A was detected in the terminal bronchioli and alveolar spaces of fetuses >35 
weeks gestation. The intra-alveolar SP-A expression increased in the perinatal period 
followed by a marked drop in infants aged between 1 week and 5 months. Infants older than 
5 months of age had abundant SP-A expression corresponding to older children and adults. 
There was no difference in the age distribution between cases of SIDS and explained 
deaths.  
 
Conclusions: The apparent drop in SP-A expression takes place in the first months after 
birth, corresponding with the classical age peak of SIDS. We therefore hypothesize that low 
expression of SP-A may be related in some as yet undetermined way to the increased risk 
of SIDS at that age. 
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4.4 Publication IV 
 
Stray-Pedersen A, Opdal SH, Vege A, Moberg S, Rognum TO. Surfactant protein A and 
D genetic variants and protein expression – a possible association with Sudden infant 
death syndrome. Submitted*. 
 
Gene polymorphisms in surfactant protein A (SP-A) and surfactant protein D (SP-D) has 
been associated with several respiratory disorders in infancy and genetic variants of 
mannose-binding lectin (MBL) are known to increase the susceptibility to infections. We 
performed genotyping of SP-A, SP-D and MBL in infants that had died suddenly, and 
investigated whether immunohistochemical expression of SP-A and SP-D is dependent 
upon the variants of the genes examined. Genotyping of the SP-A genes (SP-A1 and SP-
A2), SP-D and MBL was performed in 42 SIDS and 46 explained sudden infant deaths. 
Immunohistochemical SP-A and SP-D expression in tissues from lung and upper 
alimentary tract was evaluated by a semi-quantitative scoring system. 
 
Results: Immunohistochemical SP-A and SP-D expression in tissues from lung and upper 
alimentary tract was evaluated by a semi-quantitative scoring system. The most common 
SP-A haplotype, 6A2/1A0, tended to be overrepresented in the cases with low 
immunohistochemical SP-A expression (61%) compared to cases with high expression 
(49%), p=0.08. The SP-D expression was not determined by the 11 C/T or 160 A/G single 
nucleotide polymorphisms. Homozygous allele variants of MBL which are associated with 
low plasma levels, were found in only 1% of sudden infant deaths. 
 
Conclusions: Though no significant relationships between the investigated SP-A and SP-D 
gene variants and the SP-A and SP-D tissue expression were found, the significance of the 
SP-A haplotype 6A2/1A0 should be further explored. No association between SIDS and the 
genetic variants of SP-A, SP-D and MBL is indicated by the present study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Revised manuscript accepted for publication in Acta Paediatr.  
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5 General discussion 
The four original papers, on which this thesis is based, represent studies regarding the role 
of H. pylori infection and the innate immunity components SP-A, SP-D and MBL in 
infancy with special emphasis to SIDS. In this section, the study findings will be discussed 
in the context of the Fatal triangle explaining SIDS (Figure 2).  
 
5.1 The Fatal triangle  
The fatal triangle for SIDS38 was inspired by Valdes-Dapena’s suggestion from 1985143 that 
SIDS might be a bi-phasic phenomenon: 
 
1. Before birth the infant may be subjected to adverse intrauterine influences, e.g. 
maternal smoking, poor maternal nutrition and maternal anaemia, making it subtly 
functionally handicapped and thus predisposed to SIDS after birth.  
 
2. After birth, the infant may be “challenged” by a trigger - some external or internal 
factor with which he or she could not cope, e.g. an upper respiratory infection, an 
episode of regurgitation and choking, etc.  
 
Bearing in mind the typical peak of SIDS occurrence between the second and the fourth 
month after birth especially significant during the 1980’ties, Rognum and Saugstad added a 
third phenomenon: a vulnerable developmental stage and included genetic make-up as an 
additional predisposing factor38. It soon turned out that other researchers had similar ideas:  
Hannah Kinney’s group at Harvard Medical School launched their triple risk model144 and 
Kahn’s research group proposed a multifactorial model including three sets of factors145. 
 
In 2002 Guntheroth and Spiers36 discussed the different models and stated that in fact 
Wedgewood already in 1972 had grouped risk factors into the first “triple risk hypothesis”. 
The risk factors consisted of general vulnerability, age specific risks and precipitating 
factors. Guntheroth and Spiers stated that all three triple risk hypotheses are fairly similar36. 
The fatal triangle is shown above (Figure 2). 
 
5.1.1 Predisposing factors 
Predisposing factors may origin from fetal life and be due to a variety of adverse 
intrauterine influences, e.g. maternal smoking, maternal nutrition, maternal anemia143. One 
of these factors, brain stem astrogliosis, may have been caused by hypoxic events22,27, and 
also theoretically by infection82;146. Brain stem astrogliosis is described in SIDS by several 
authors23-25;147 . 
 
The genetic “make-up” i.e. individual variants in the genome may also constitute 
predisposing factors. Several studies have aimed at finding the SIDS gene148, however only 
a few of the proposed candidates genes have thus far been supported by evidence:  
 
 Substitutions, mutations and genetic variants of mitochondrial DNA have been 
reported in individual cases but no predominant mtDNA mutation has so far been 
found to be associated with SIDS in case control studies163.  
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 Polymorphisms in the IL-10 gene have been found to be associated with sudden 
deaths in infancy due to infectious disease and is perhaps also playing a role in a 
proportion of SIDS cases93; 149; 150. 
 
 Another investigated candidate has been the IL-6 gene: A genotype determined by a 
single nucleotide polymorphism (174 G/C) has been found in increased frequency in 
Australian91 and British SIDS victims151, but not in Hungarian or German91, and not 
in Norwegian SIDS victims92.  
 
 Partial deletions of the complement factor 4 (C4) gene in combination with slight 
upper airway infections have been related to an increased risk for SIDS152-154.  
 
 Genes involved with thermal balance has so far not been related to SIDS155;156. 
 
 Recent studies on genetic variants in the Serotonin transporter (5-HTT) gene also 
seem compelling. An increased frequency of a long allele polymorphism, giving an 
especially high serotonin reuptake, has been found in Japanese SIDS victims157, in 
black158, and white American victims (Paterson et al - abstract presented at 
International congress on sudden unexpected death in Infancy, Soria Moria, Oslo, 
Nov 2007), and in Norwegian victims (Opdal et al 2008: personal communication). 
An insertion mutation possibly affecting 5-HT neuronal development was also 
recently reported in 6 out of 49 black American SIDS victims compared to none of 
the controls159. 
 
  Genetic variants of the Long QT syndrome (LQTS) genes were recently 
demonstrated in 19 of 201 cases originally diagnosed by us as SIDS17. The genetic 
alterations were shown to be functionally significant by electro-physiologic 
analysis, implying that the cause of death was cardiac arrhythmia rather than SIDS 
in 16 of the cases, whereas in 3 cases the gene variant may have served as a 
predisposing factor for SIDS, exhibiting depolarization shift under conditions of 
internal acidosis161. Furthermore, a newly discovered mutation (GPD1-L) associated 
with alteration in the function of cardiac sodium channels was recently reported in 3 
out of 304 German infants, originally classified as SIDS162. 
 
5.1.2 Vulnerable developmental stage 
The “critical” age peak for SIDS has been shown to be from 2 to 4 (5) months of age in 
different populations10;50;52;160. These first post-natal months represent a critical period for 
homeostatic control. The infant goes through a period of “reflex chaos” in which fetal 
reflexes vanish and aimed voluntary movements are not yet developed13. The consequence 
may be the inability to turn the head to the side in case of a dangerous prone sleeping 
position with the face down in a soft mattress. 
 
Other developmental changes in autonomic nervous control, i.e. changes in respiration and 
heart rate, also occur at this stage of development164. Wailoo’s research group has shown 
that infants change from infant- to adult-like night-time body temperatures at some 
individual point between 2 and 4 months of age71. Changes in night-time heart rate and 
deep sleep duration occur at the same time71.  
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The immunologically “naive” newborn infant is protected against infections by maternally-
derived antibodies. After the perinatal period, in the first months of life, these antibodies 
disappear and following the exposure to various microbes, the infant’s ability to generate a 
primary immune response is generated84-86.  
 
5.1.3 Trigger event 
The vast majority of infants of mothers who smoke and infants carrying genetic 
predisposition for immunological dysfunction, survive the vulnerable phase. The trigger 
initiating the death mechanism may be bed-sharing in inappropriate circumstances, or the 
combination of prone sleeping and a slight infection. A relationship between SIDS deaths 
and the month-to-month variation in Bordetella pertussis infection has been shown, and in 
Norway during a whooping-cough epidemic, a significant increase in SIDS rates was 
observed74. Respiratory virus RNA has been detected by PCR in lung tissue more 
frequently in SIDS victims than in non-SIDS cases77. The seasonal variation involving a 
winter peak is considered typical not only for SIDS, but is also an observable phenomenon 
in respiratory virus epidemics, and it has been hypothesized that the SIDS rate is affected 
by outbreaks of respiratory virus epidemics75;76.  
 
We have compared the SIDS rate in Norway with the registered numbers of Respiratory 
Syncytial Virus (RSV) and Influenzae virus identifications reported to the Norwegian 
Institute of Public Health (abstract presented at International congress on SUDI, Soria 
Moria, Oslo, October 2004). Although the dominant feature was that the SIDS rate 
decreased from 37 cases in 1993 to 20 cases in 2005 (Figure 6), minor changes in the SIDS 
rate seem to follow the biannual peak of virus epidemics.  
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 5.2 Helicobacter pylori – a possible role in SIDS? 
5.2.1 Marshall’s hypothesis 
In 1997, Pattison and Marshall proposed that H. pylori infection115 may play the role of an 
exogenous trigger in SIDS. They hypothesized that H. pylori infection may result in 
production of large amounts of urease which, if aspirated with gastric juice, could reach the 
alveolae, react with plasma urea, and produce ammonia toxicity inducing respiratory arrest. 
An alternative postulated mechanism may be release of inflammatory cytokines induced by 
H. pylori infection, resulting in disturbed homeostasis of the immune system, inducing high 
fever and increased deep sleep leading to critical hypoxemia, coma and death115.  
 
5.2.2 Epidemiological evidence 
The association between H. pylori infection and SIDS is to some extent supported by 
epidemiological data. Both H. pylori infection and SIDS is associated with poor 
socioeconomic conditions49;165. SIDS is a disease of infants younger than one year10. In 
developing countries, it has long been appreciated that H. pylori infection occurs within the 
first year of life100. In paper I, evidence is brought to support that infants in a developed 
country also encounter H. pylori in early infancy. It has been argued that the SIDS rate in 
developing countries is low166, but this is most likely due to poor post mortem 
investigations and over-shadowing by a huge infant mortality rate due to infectious disease. 
However, other risk factors for SIDS such as male gender predominance, prematurity and 
maternal smoking, have thus far not shown any association with H. pylori infection. 
 
5.2.3 Previous experimental work 
In the year 2000, Kerr et al reported PCR findings suggestive of H. pylori infection in 
28 of 32 SIDS cases compared to only 1 of 8 controls and concluded that a causative role 
for H. pylori in SIDS was likely116. The study was heavily criticized, the study findings 
were argued to result of false positive PCR products due to contamination167. Four 
subsequently published small-number studies were unable to confirm Kerr’s 
results117;118;168;169. H. pylori bacilli were not documented histopathologically in any of the 
studies. 
 
5.3 Methodological considerations 
We selected a different approach to investigate the role of H. pylori in SIDS, designing a 
large sample case-control study and using the H. pylori stool antigen (HpSA) test to detect 
H. pylori infection - a test which has been developed particularly for pediatric 
populations170. In paper II we present that detection of H. pylori antigen is significantly 
associated with SIDS compared to live controls (Paper II). The validity of the test is 
confirmed by histology. The methodological and clinical considerations concerned with the 
study findings are discussed below. 
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5.3.1 The accuracy of the HpSA test 
The HpSA ELISA test has been widely used in clinical pediatric practice with an adequate 
sensitivity and specificity for detecting H. pylori infection, between 85-100% and 82-99% 
respectively, which is comparable to the Urea breath test171. The diagnostic accuracy has 
been decent in both high and low prevalence populations170;172. The test utilizes polyclonal 
antibodies, and has now been replaced by a monoclonal kit (HpSAplus) with only slightly 
improved precision173. However, the possibility of cross-reaction with other bacteria or 
antigens can not be ruled out with the polyclonal test. 
 
5.3.2 Effects of decomposition and autolysis 
Investigations on material obtained at autopsy are invariably influenced by autolysis. 
Decomposition of organ tissue begins shortly after death. Good controls are therefore a 
prerequisite for such research. We first performed the HpSA test in fresh stool samples 
from 249 infants and children. The HpSA test results in stool samples obtained during 
autopsy of victims of accidental deaths did not differ significantly from the age-matched 
live controls (9% and 8% respectively). Thus, the HpSA test seems to behave similarly in 
stool samples from live and dead infants. The interval between time of death and autopsy 
was less than three days in all cases, median 19 hrs.  
 
5.3.3 H. pylori and the immune response 
Curved or rod-like H. pylori structures were detected by histology, but signs of acute 
inflammation was not observed in any of the cases. The expression of IgA, IgG, and IgM 
immunocytes in the gastric mucosa was studied in 45 of the sudden infant deaths presented 
in paper II. However, this immune staining evaluation was not included in the final 
manuscript to avoid excess information. The amounts of IgA expressing immunocytes 
present in the gastric mucosa increased significantly with age the first 6 months of life. On 
the other hand, the amounts of IgG and IgM immunocytes were in most cases low for all 
ages. Similar observations have been made in other tissues previously, e.g. trachea and 
duodenum85;86 . There was a trend that HpSA positive infants between 1 and 5 months of 
age showed a higher expression of IgA immunocytes in the gastric mucosa than HpSA 
negative infants. No differences were observed with regard to IgG and IgM expression 
(Figure 7). We speculate that the inability to detect significant mucosal immune stimulation 
and signs of inflammation, is largely due to autolysis. However, central immune 
stimulation, reflected by elevated IL-6 levels in CSF, showed a significant association with 
H. pylori infection.   
 
5.3.4 H. pylori detection rate affected by age  
Unanticipated findings are one of the thrills involved with basic medical research. 
Originally, we did not intend to investigate the H. pylori detection rate in live newborn 
control infants. The unexpected finding that the rate of H. pylori detection was higher in 
infants between 7 days and 1 month of age (15%) compared to all other age groups (3-10%) 
prompted the collection of samples from neonates. H. pylori antigen was detected in the 
meconium samples from more than half of the newborn infants (paper I). The OD-values of 
the positive tests were mostly well above the threshold of 0.160, with several of the tests 
above 2.0, similar to the positive control reagent supplied with the kit.  
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Fujimura et al has investigated stool samples from 50 Japanese infants at 3 days of age and 
found only one infant (2%) testing positive by the HpSA method, but 15 (30%) testing 
positive by PCR174. We are unable to clarify the discrepancy between their findings and 
ours. One difference between their study and ours is that we collected most of the samples 
within 12 hours after birth, and all within 2 days, whereas Fujimora et al obtained samples 
at day 3. 
 
5.3.5 PCR of H. pylori DNA 
In an attempt to confirm our results, we performed PCR analyses and verified the presence 
of H. pylori DNA in 35% of the HpSA positive samples tested. In our opinion, this 
provides evidence that positive HpSA tests in newborn infants are not likely due to cross-
reactions i.e. with perinatal transitory antigens, but probably represent presence of H. pylori 
bacteria in the stool. The difficulties of performing PCR in stool-extracted DNA are well 
recognized, and arise due to the presence of PCR inhibitors and local variations in DNA 
density within the stool. This explains the divergence between the HpSA- and the PCR 
findings. 
 
5.3.6 H. pylori in neonates - transmission from mother to child? 
The findings in paper I indicate that a great proportion of infants encounter H. pylori in the 
neonatal period. The fact that H. pylori antigen in the present study was detected in only 
10% of the infants delivered by cesarean section compared to 59% of infants born by 
vaginal births, suggests that transmission from mother to child probably occurs during the 
baby’s passage through the birth canal. As the H. pylori detection rate in infants dropped 
after the perinatal period and remained low for all other age groups in infancy and 
childhood, the encounter is not likely to result in a persistent infection in individuals of 
normal health. The luminal content of the fetal gastrointestinal tract consists of sterile 
meconium which is colonized with bacteria shortly after birth. The timing and composition 
of bacterial colonization has been shown to be determined by the mode of delivery and 
maternal vaginal microbes have been detected in the stool of neonates born by vaginal 
births175. A Pubmed search reveals that efforts to investigate the development of the normal 
infant microbiota have been rather modest in later years. However, Palmer et al recently 
collected repeated stool samples of infants from birth to one year of age, and performed 
microarray to detect bacterial rRNA176. They showed that great changes occur in the 
intestinal microbiota in most individuals in the first months of life. 
 
5.4 Clinical significance of H. pylori in newborn infants 
In paper I we concluded that H. pylori is probably transmitted from mother to child at the 
time of birth. However, based on the study findings, this would indicate that more than half 
of the Norwegian mothers are carriers of H. pylori. Data from the HUNT study suggest that 
only 10-15% of Norwegian women at a fertile age are H. pylori positive by serology177. 
Thus a large proportion of women either do not show an immune response against their H. 
pylori infection, or the women acquire their H. pylori infection in pregnancy and/or do not 
develop an immune response.  Interestingly, studies have shown that H. pylori (re-
)infection in pregnancy may occur and an association between hyperemesis gravidarum has 
been found178. There is also emerging evidence that H. pylori might enter into a viable, but 
not culturable state – a coccoid form which has been observed in colonies suffering stress 
and nutrient depletion in laboratory conditons179;180.We speculate that H. pylori organisms 
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in some form are introduced to infants shortly after birth and are “flushed” through the 
gastrointestinal tract within the first week(s) of life in healthy individuals. The existence of 
H. pylori bacteria in a viable, non-virulent form in the gastro-intestinal tract, could explain 
the obvious incongruity between the HpSA test findings in newborn infants and the 
predicted H. pylori prevalence in their mothers. A follow-up study testing both mothers and 
infants may disclose the transmission pathway, and is in progress.   
 
5.5 Clinical significance of H. pylori infection in SIDS 
The drop in SIDS rate following the intervention programs directed against prone sleeping 
and smoking in pregnancy, predominantly involved young infants between 1-5 months of 
age whereas older infants were less affected52. In paper II we show that the difference in H. 
pylori infection rate between SIDS and controls is predominantly seen in infants aged 
between 1-5 months. Furthermore, in paper III we present that infants in this age group 
express low surfactant protein A in their lungs.  There is now substantial evidence that in a 
large proportion of SIDS cases (~50%) the death mechanism may be induced by 
disturbances in the immunological homeostasis caused by a combination of genetic 
predisposition and a trigger event at this vulnerable stage in development 13;38;181. H. pylori 
may represent a biomarker to detect such cases of SIDS. We speculate that  
H. pylori infection contribute to the microbial load, and trigger the death mechanism in 
SIDS (Figure 8). 
 
 
5.6 Collectins –significance for SIDS? 
In paper III we present that SP-A expression drops in the first months after birth, 
corresponding with the classical age peak for SIDS. In what manner this phenomenon is 
related to SIDS other than adding to the burden of vulnerability in the first months of life 
(Figure 8), remain unidentified. SP-A plays a structural role within the surfactant 
phospholipid127 and, hypothetically, a deficiency in SP-A function would explain the 
findings of partial atelectasis which is a common feature in infant deaths at this age. 
However, we were unable to find an association between observed atelectasis and high or 
low SP-A expression. Further studies are needed to elucidate the role of the dip in SP-A 
expression in the post-natal period. Evaluating the amount of SP-A transcripts by Real-time 
PCR technology would be a valuable contribution, but is difficult to perform on material 
obtained at autopsy due to rapid autolysis of mRNA after death. 
 
Recent studies have shown that Surfactant protein D is involved in the immune response to 
H. pylori108;182. Both SP-A and SP-D are powerful modulators of the immune response88. A 
deficiency in these innate components has not yet been observed in humans, but may in 
theory contribute to the immunological disturbance in SIDS. A state of clinical deficiency 
in the third collectin, MBL, is fairly common (~1% of the population) and is associated 
with increased susceptibility to infections132. The aim of the study presented in paper IV 
was to elucidate whether genetic variants of the collectins could be associated with SIDS. 
We report that no significant associations with SIDS are found. However, the study is, like 
several gene association studies, limited by the fact that only the currently well-
characterized polymorphisms in the coding exons were investigated. The traditional PCR-
methodology used is accurate, but time-consuming. New technology enabling rapid 
detection of polymorphic sites generates new opportunities for genetic research, and the 
possibility of detecting yet unidentified gene variations.  
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6 Conclusions 
 
1. Helicobacter pylori stool antigen is detected in the primary meconium discharge of 
60% of Norwegian newborn infants delivered vaginally compared to 10% of infants 
delivered by cesarean section. Transmission of H. pylori most likely occurs from 
mother to child related to the baby’s passage through the birth canal. After the 
neonatal period the detection rate in healthy Norwegian infants is low (~5%), 
indicating a transient infection in most cases.  
 
2. H. pylori infection in post-natal infants, confirmed by the HpSA test and by immune 
staining of gastric tisse, is associated with SIDS and sudden deaths in infancy due to 
infectious disease, particularly for infants between 1 and 5 months of age. Elevated 
interleukin-6 levels in cerebrospinal fluid were found in H. pylori positive SIDS 
victims, indicating a contribution to the “load” of triggering events in SIDS.  
 
3. Abundant surfactant protein A (SP-A) expression is demonstrated in neonates born 
to term. Low SP-A expression is observed in infants of post-natal age between 2 
weeks and 5 months of age, coinciding with the critical age peak for SIDS, thus 
contributing to the crtical developmental stage. 
 
4. The common SP-A haplotype 6A2/1A0 tends to be associated with low protein 
expression in post-natal infants. Genetic variants of surfactant protein D (SP-D) 
determined by polymorphisms at aa11 and aa160 are not associated with high/low 
protein expression. Genetic variants of SP-A, SP-D or mannose-binding lectin, 
MBL, are not associated with SIDS. 
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Errata 
 
1. In the original manuscript, a system error had occurred in the Reference manager 
software program prior to printing. All in-text reference codes in the general discussion 
had shifted one paragraph up; i.e. the reference code at the end of one paragraph 
belonged to the subsequent paragraph with reference code. 
2. (p8) Deleted misprint ”the of the”. 
3. (p8) “Dr. Shelly Tonkin” corrected to “Dr. Shirley Tonkin” 
4. (p11) “the relative percentage of explained deaths have increased” corrected to “…has 
increased” 
5. (p11) “deaths scene investigation” corrected to “death scene investigation” 
6. (p13) “seem” corrected to “seems”  
7. (p14) “infectious deaths” corrected to “deaths due to infections” 
8. (p15) “a factor in SIDS” changed to “contributory factors to SIDS” 
9. (p16) “gene polymophisms was” corrected to “…were”  
10. (p16) “SIDS took an intermediate position indicating that IL-10 behaves like in 
infectious deaths in a proportion of the SIDS victims” changed to “…intermediate 
position between deaths due to infections and controls.” 
11. (p17) “the prevalence in children is low” changed to “…is presumably low” 
12. (p17) “flagella” corrected to “flagellae” 
13. (p18) “still not fully understood” changed to “yet incompletely understood” 
14. (p19) “they” changed to “these” 
15. (p19) “SP-B and SP-C are small hydrophobic…” moved down one paragraph. 
16. (p19)  the phrase “…members of the collectin family of proteins” deleted 
17. (p21) “One aim” changed to “The aim” 
18. (p23) “Rikshosptialet” corrected to “Rikshospitalet” 
19. (p23) “haplotypes” changed to “haplotyping” 
20. (p31) “anemia” corrected to “anaemia” 
21. (p31) “some external or internal factor as a trigger” changed to “trigger – some 
external or…” 
22. (p31) “of occurrence of SIDS” changed to “of SIDS occurrence” 
23. (p31) corrected misprints in the following words: “researchers”, “in”, “stated”, 
“genome” 
24. (p32) “were also recently been reported” changed to “was recently reported” 
25. (p32) “developmental” corrected to “developmental” 
26. (p33) “Most frequently, infants…” changed to “The vast majority of infants…” 
27. (p35) “finding” corrected to “findings” and the phrase “…shown to be” deleted 
28. (p36) “from age-matched controls” changed to “from the age-matched live controls” 
29. (p37)  Figure 7 missing in original manuscript 
30. (p38) “normal health individuals” changed to “individuals of normal health” 
31. (p39) “showed” changed to “show” and “present” 
32. (p39) “We showed in paper III” changed to “In paper III we present” 
33. (p40) “Microarray” changed to “Real-time PCR” and “gene-sequencing” deleted 
 
 
